Feasibility of Assessing Patient Health Benefits and Incurred Costs Resulting from Early Dysphagia Intervention during and Immediately after Chemoradiotherapy for Head-and-Neck Cancer
Author(s) -
Rosemary Martino,
Jolie Ringash,
L. C. Durkin,
Elissa Greco,
Shao Hui Huang,
Wei Xu,
Christopher J. Longo
Publication year - 2017
Publication title -
current oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.053
H-Index - 51
eISSN - 1718-7729
pISSN - 1198-0052
DOI - 10.3747/co.24.3543
Subject(s) - medicine , dysphagia , percutaneous endoscopic gastrostomy , head and neck cancer , swallowing , quality of life (healthcare) , physical therapy , cohort , body mass index , gastrostomy , cancer , surgery , peg ratio , nursing , finance , economics
Resource limitations affect the intensity of speech-language pathology (slp) dysphagia interventions for patients with head-and-neck cancer (hnc). The objective of the present study was to assess the feasibility of a prospective clinical trial that would evaluate the effects on health and patient costs of early slp dysphagia intervention for hnc patients planned for curative concurrent chemoradiotherapy (ccrt).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom